iPSC-based Cancer Vaccine

About Khloris Biosciences

Khloris Biosciences is a private, pre-clinical stage biotech developing first-in-class iPSC-based cancer vaccines and cell therapies. The company's platform leverages a large, diverse biobank of human iPSC lines to create vaccines designed to elicit a broad anti-tumor immune response. Khloris has established a key strategic collaboration with Leaps by Bayer, Bayer's investment arm, to advance its anti-cancer vaccine programs, positioning it to address significant unmet needs in oncology and cardiology.

Therapeutic Areas

Other Cancer (Broad) Drugs